Suchergebnisse - "Valcarcel, Sena"

PubPharm (4)

1

EGFR exon 18 delE709_T710insD mutated stage IV non-small cell lung cancer treated with osimertinib : a case report

enthalten in: Anti-cancer drugs | 2024

von Valcárcel, S. | Villanueva, N. | Álvarez, C. | +1

2

Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry

enthalten in: Journal of cancer research and clinical oncology | 2023

von Valcarcel, S. | Gallego, J. | Jimenez-Fonseca, P. | +26

3

Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry

enthalten in: Journal of cancer research and clinical oncology | 2022

von Valcarcel, S. | Gallego, J. | Jimenez-Fonseca, P. | +26

4

Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry

enthalten in: Journal of cancer research and clinical oncology | 2022

von Valcarcel, S. | Gallego, J. | Jimenez-Fonseca, P. | +26

1
[1]